Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Daneman

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
The Journal of Clinical Investigation|February 28, 2023
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilegeYinghua Ma, David Sannino, Jennifer R Linden, et al.
Nature|September 3, 2025
Dynamic fibroblast-immune interactions shape recovery after brain injuryNathan A Ewing-Crystal, Nicholas M Mroz, Amara Larpthaveesarp, et al.
Nature Communications|September 7, 2023
Author Correction: CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Nature Communications|August 19, 2023
CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
The Journal of Clinical Investigation|February 28, 2023
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilegeYinghua Ma, David Sannino, Jennifer R Linden, et al.
Nature|September 3, 2025
Dynamic fibroblast-immune interactions shape recovery after brain injuryNathan A Ewing-Crystal, Nicholas M Mroz, Amara Larpthaveesarp, et al.
Nature Communications|September 7, 2023
Author Correction: CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Nature Communications|August 19, 2023
CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Pageof 8